Viewing Study NCT04764981



Ignite Creation Date: 2024-05-06 @ 3:48 PM
Last Modification Date: 2024-10-26 @ 1:57 PM
Study NCT ID: NCT04764981
Status: UNKNOWN
Last Update Posted: 2021-02-21
First Post: 2021-02-14

Brief Title: Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 COVID-19
Sponsor: Universidade do Estado do ParĂ¡
Organization: Universidade do Estado do ParĂ¡

Study Overview

Official Title: Clinical Outcomes of Olfactory Training for Treatment of Olfactory Dysfunction After COVID-19
Status: UNKNOWN
Status Verified Date: 2021-02
Last Known Status: ENROLLING_BY_INVITATION
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: It is a randomized controlled clinical trial study that aims to follow a sample of individuals with persistent olfactory dysfunction post-COVID-19 The aim of this study is assess the clinical outcomes of olfactory training therapy in the treatment of persistent olfactory dysfunctions after COVID-19 The sample will consist of 350 participants being 300 individuals with persistent olfactory dysfunction post-COVID-19 and 50 healthy individuals Volunteers will be separated in two experimental groups 1 and 2 and a control group All participants will be submitted to clinical evaluation that include the Connecticut Chemosensory Clinical Research Test CCCRT an olfactory test to diagnose anosmia and hyposmia and two skull Magnetic Resonance imaging MRI Only participants of Experimental group 1 will be submitted to an olfactory training with essences oils Experimental group 2 will only receive a clinical follow-up after three months and control group will be only submitted to neurological exam olfactory test MRI imaging and test their ability to discriminate the essence oils used in olfactory training As a result is expected a better understanding of the characteristics of olfactory dysfunction caused by Severe Acute Respiratory Syndrome Coronavirus-2 SARS-CoV-2 virus infection as well as the effectiveness and viability of using Olfactory Training as a therapeutic alternative
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None